Peijia Medical (09996) Sets 25 Mar 2026 Board Meeting to Approve FY2025 Results and Mull Final Dividend

Bulletin Express

03/13

Peijia Medical Limited (Stock Code: 09996) has scheduled a board meeting for 25 March 2026 to review and approve the consolidated results for the financial year ended 31 December 2025. The agenda also includes considering a recommendation for a final dividend, according to a filing released on 13 March 2026.

The board is chaired by Executive Director Dr. Yi Zhang and currently comprises ten members: three executive directors (Dr. Yi Zhang, Mrs. Ping Ye Zhang, Ms. Hong Ye), three non-executive directors (Mr. Jifeng Guan, Mr. Fei Chen, Mr. Jun Yang) and four independent non-executive directors (Dr. Stephen Newman Oesterle, Mr. Robert Ralph Parks, Mr. Wai Ming Yip, Mr. Huacheng Wei).

The company will release its audited FY2025 results and any dividend proposal following the board’s approval.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1150763951"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1150763951\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1150763951?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-13 17:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1150763951","market":"hk","top_or_hot":-1,"title":"Peijia Medical (09996) Sets 25 Mar 2026 Board Meeting to Approve FY2025 Results and Mull Final Dividend","media":"Bulletin Express","content":"<p>Peijia Medical Limited (Stock Code: 09996) has scheduled a board meeting for 25 March 2026 to review and approve the consolidated results for the financial year ended 31 December 2025. The agenda also includes considering a recommendation for a final dividend, according to a filing released on 13 March 2026.</p>\n<p>The board is chaired by Executive Director Dr. Yi Zhang and currently comprises ten members: three executive directors (Dr. Yi Zhang, Mrs. Ping Ye Zhang, Ms. Hong Ye), three non-executive directors (Mr. Jifeng Guan, Mr. Fei Chen, Mr. Jun Yang) and four independent non-executive directors (Dr. Stephen Newman Oesterle, Mr. Robert Ralph Parks, Mr. Wai Ming Yip, Mr. Huacheng Wei).</p>\n<p>The company will release its audited FY2025 results and any dividend proposal following the board’s approval.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Peijia Medical (09996) Sets 25 Mar 2026 Board Meeting to Approve FY2025 Results and Mull Final Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPeijia Medical (09996) Sets 25 Mar 2026 Board Meeting to Approve FY2025 Results and Mull Final Dividend\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-03-13 17:02</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Peijia Medical Limited (Stock Code: 09996) has scheduled a board meeting for 25 March 2026 to review and approve the consolidated results for the financial year ended 31 December 2025. The agenda also includes considering a recommendation for a final dividend, according to a filing released on 13 March 2026.</p>\n<p>The board is chaired by Executive Director Dr. Yi Zhang and currently comprises ten members: three executive directors (Dr. Yi Zhang, Mrs. Ping Ye Zhang, Ms. Hong Ye), three non-executive directors (Mr. Jifeng Guan, Mr. Fei Chen, Mr. Jun Yang) and four independent non-executive directors (Dr. Stephen Newman Oesterle, Mr. Robert Ralph Parks, Mr. Wai Ming Yip, Mr. Huacheng Wei).</p>\n<p>The company will release its audited FY2025 results and any dividend proposal following the board’s approval.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09996","symbol_name":"沛嘉醫療-B","start_time":0,"source_url":"","article_id":"1150763951","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1150763951","pubTimestamp":1773392576,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Peijia Medical Limited (Stock Code: 09996) has scheduled a board meeting for 25 March 2026 to review and approve the consolidated results for the financial year ended 31 December 2025. The agenda...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09996":"沛嘉医疗-B"},"translate_title":"沛嘉医疗(09996)定于2026年3月25日召开董事会批准2025财年业绩并考虑末期股息","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09996":1},"content_text":"Peijia Medical Limited (Stock Code: 09996) has scheduled a board meeting for 25 March 2026 to review and approve the consolidated results for the financial year ended 31 December 2025. The agenda also includes considering a recommendation for a final dividend, according to a filing released on 13 March 2026.\nThe board is chaired by Executive Director Dr. Yi Zhang and currently comprises ten members: three executive directors (Dr. Yi Zhang, Mrs. Ping Ye Zhang, Ms. Hong Ye), three non-executive directors (Mr. Jifeng Guan, Mr. Fei Chen, Mr. Jun Yang) and four independent non-executive directors (Dr. Stephen Newman Oesterle, Mr. Robert Ralph Parks, Mr. Wai Ming Yip, Mr. Huacheng Wei).\nThe company will release its audited FY2025 results and any dividend proposal following the board’s approval.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"conferences,SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}